Product NDC: | 54569-0838 |
Proprietary Name: | Orphenadrine Citrate |
Non Proprietary Name: | Orphenadrine Citrate |
Active Ingredient(s): | 100 mg/1 & nbsp; Orphenadrine Citrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54569-0838 |
Labeler Name: | A-S Medication Solutions LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040284 |
Marketing Category: | ANDA |
Start Marketing Date: | 19980619 |
Package NDC: | 54569-0838-1 |
Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (54569-0838-1) |
NDC Code | 54569-0838-1 |
Proprietary Name | Orphenadrine Citrate |
Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (54569-0838-1) |
Product NDC | 54569-0838 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Orphenadrine Citrate |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19980619 |
Marketing Category Name | ANDA |
Labeler Name | A-S Medication Solutions LLC |
Substance Name | ORPHENADRINE CITRATE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |